Updates on These Three Mining Stocks
Source: Clive Maund  (9/19/22)
Expert Clive Maund takes a look at charts from Infinitum Copper Corp., Reyna Gold Corp., and Reyna Silver Corp. to tell you where he thinks these three mining stocks are going. More >

Mining Co. Reports More Good Drill Results in Spain
Source: Adam Schatzker  (9/19/22)
"It certainly appears that Romanera could prove to be a significant precious metals deposit," noted a Research Capital Corp. report. More >

Top-10 Producer Offers $150M for Nevada Gold Property
Source: Streetwise Reports  (9/19/22)
Coeur Mining Inc. shares traded 18% higher after the company reported it has agreed to sell its Southern Nevada Holdings to AngloGold Ashanti Ltd. for $150 million in cash. The purchase by AngloGold includes provisions for an additional payment of $50 million if the project is shown to host a total resource of 3.5 million ounces of gold or higher. More >

Second Trial of New Eczema Drug To Commence in Q4/22
Source: Dr. Yi Chen  (9/17/22)
The purpose behind this complementary study is to potentially expand the treatment's target patient population, noted an H.C. Wainwright & Co. report. More >

Silver Explorer Expands Golden Triangle Drilling Campaign
Source: Streetwise Reports  (9/16/22)
Dolly Varden Silver Corp. is adding a fourth diamond drilling rig to its campaign at its Kitsault Valley project in British Columbia after seeing big returns. More >

Tech Co. Ready To Advance in a New Bull Market
Source: Clive Maund  (9/16/22)
Expert Clive Maund reviews Danavation Technologies Corp. after the completion of a large base pattern to see whether he believes it is a Buy. More >

Junior Closes on Deal for Critical Metals, Minerals Project
Source: Streetwise Reports  (9/16/22)
Copper and other critical metals and minerals are the backbone of the world's switch to green energy, and Rover Metals Corp. hopes to supply some of them. More >

FDA Grants Approval for Drug Improving Kidney Function
Source: Streetwise Reports  (9/16/22)
Shares of Mallinckrodt Plc. traded 28% higher yesterday after the company reported that the U.S. FDA has issued approval for its Terlivaz® (terlipressin) for injection for use in treating hepatorenal syndrome, a serious and life-threatening condition that is accompanied by rapid reduction in kidney function. More >

Bowling Center's Shares Score New 52-Week High
Source: Streetwise Reports  (9/16/22)
Shares of bowling center operator Bowlero Corp. traded 7.5% higher and rolled to a new 52-week high after the company reported Q4/22 and FY/22 financial results that included a 130.7% YoY increase in annual revenue. More >

Price Target on US Biopharma Co. Boosted by $15
Source: Julian Harrison  (9/15/22)
The increase came after positive clinical trial results on one of its lead drug candidates differentiating it from a competitor, noted a BTIG report. More >

New Drug Shown To Help Patients With Desmoid Tumors
Source: Dr. David Nierengarten  (9/15/22)
This oral gamma-secretase inhibitor met the primary and secondary endpoints in a Phase 3 clinical trial, noted a Wedbush report. More >

Three-Part Approach to Advancing Gold Project Gets Results
Source: Mike Niehuser   (9/15/22)
The explorer recently hit upon the main deposit's feeder zone, discovered a new vein nearby and keeps drilling high-grade gold intercepts, noted a ROTH Capital Partners report. More >

Publishing Co. Rated an 'Interesting Speculative Play'
Source: Clive Maund  (9/15/22)
After a relatively big buyer appeared a week ago and bought a lot of stock from Legible Inc., expert Clive Maund believes something may be on the horizon for the publishing company. More >

NDA for Dry Eye Disease Drug on Track for Q4/22 Submission
Source: Justin Kim   (9/15/22)
This and the biopharma's other treatment candidates for ocular diseases are underappreciated, which translates to an investment opportunity, noted an Oppenheimer report. More >

Several Trials of Co.'s Fluid Pump To Read Out This Year
Source: Dr. Yi Chen  (9/14/22)
Positive topline data could boost the share price of this Swiss medical device firm, noted an H.C. Wainwright & Co. report. More >

Analyst Says Mining Junior Well Positioned To Ride Out Gold Bear Market
Source: Felix Shafigullin  (9/14/22)
The company has numerous elements working in its favor, including a fully permitted gold project only 12 months away from initial production, noted an Eight Capital report. More >

Copper Junior Sees 'Beautiful' Drilling Results in Mexico
Source: Streetwise Reports  (9/14/22)
Infinitum Copper Corp. hopes to help close a coming copper shortage with the red metal coming out of its La Adelita project in Mexico. More >

Oil & Gas Producer Sees 145% Rise in FY22 Production
Source: Streetwise Reports  (9/14/22)
Shares of Evolution Petroleum Corp. traded 19% higher after the U.S. onshore oil and gas producer reported that during FY/22 it increased production by 145% YoY and achieved a 233% increase in annual revenue. The company advised that it is raising its quarterly cash dividend by 20% and is initiating a $25 million share buyback program. More >

Co. Advancing Drug Class With Broad Potential
Source: Dr. Thomas Shrader   (9/13/22)
This developer of C1q-targeting therapeutics, with a catalyst-rich 18 months ahead, warrants analyst coverage, noted a BTIG report. More >

Rare Earths Co. Reaches Important Milestone Before PFS
Source: Mark Reichman  (9/13/22)
The explorer agreed to work together with a local First Nations community as it advances its critical elements project in British Columbia, noted a Noble Capital Markets report. More >

Biotech Co.'s Target Six Times Current Price
Source: Francois Brisebois  (9/13/22)
One Phase 2 clinical trial showing LSD reduced symptoms of anxiety bodes well for other studies of LSD in this indication. In light of this, Oppenheimer & Co. gave this biotech company a target price that is over six times its current share price. More >

Expert Says Life Science Co.'s Technical Setup Is 'Exceptionally Positive and Keeps Getting Better'
Source: Clive Maund  (9/13/22)
Expert Clive Maund reviews the 6-month and 15-month charts for Awakn Life Sciences Corp. to explain why he thinks this company's technical setup is exceptionally positive. More >

Hycroft Reports High Gold and Silver Grades at Nevada Mine
Source: Streetwise Reports  (9/13/22)
Shares of Hycroft Mining Holding Corp. traded 12% higher after the Nevada gold and silver mining firm reported initial drill results from its Hycroft Mine. The company commented that it has encountered multiple zones of continuous higher-grade silver that extend further than prior interpretations.
More >

Healthcare Co.'s To Develop Fast-Dissolving MDMA Tablet
Source: Streetwise Reports  (9/12/22)
One biopharma co. is teaming with a much larger pharmaceutical company to develop a fast-dissolving oral tablet to deliver MDMA to patients with Alcohol Use Disorder. Find out why developing an oral tablet could benefit the company in the long run. More >

Analyst Says Biopharma's New Inhaled Antifungal Drug Shows Promise
Source: Dr. Jonathan Aschoff  (9/12/22)
Trial results are expected later this month, but anecdotal data available now suggest the findings should be positive, noted a ROTH Capital Partners report. More >